NFCR Writer David Perry, Author at NFCR - Page 4 of 10

NFCR Writer David Perry

Alex Matter: Making Targeted Therapy a Reality

“I was attracted, even as a youngster, by infectious diseases and cancer,” recalls Alex Matter, M.D. That young boy would pursue these passions and, in adulthood, emerge as a leading global authority in the disease field. Now the CEO of the Agency for Science, Technology and Research, or A*STAR, the…...

Read more

An Analytical Tool Like Few Others

When he passed away in April 2004, Dr. Csaba Horváth had more than a few laurels upon which he could eternally rest. Though most famously, Horváth was the first scientist to design, construct and show molecular separations using high-performance liquid chromatography (HPLC). The analytical technology has since served as foundation…...

Read more

Cancer and Genomics: A Primer

In 2017, genetic researchers in the United Kingdom introduced a powerful new mechanical tool in the growing field of genomics which may guide the way to new cancer treatments. The high-tech genome sequencer, the Illumina NovaSeqTM 6000, was unveiled at The Institute of Cancer Research (the ICR) in London. “It…...

Read more

Breast Cancer Linked to Bone Marrow Cells

“Our study shows that the recruitment of bone marrow-derived fibroblasts is important for promoting tumor growth, likely by enhancing blood vessel formation,” says Dr. Neta Erez of the Sackler School of Medicine at Tel Aviv University, discussing a recent discovery finding that breast cancer can “recruit” stromal cells originally formed…...

Read more

“Pink Drink” to Aid Brain Tumor Treatment

Approved in June 2017 by the U.S. Food and Drug Administration and launched commercially in-country in October 2018, 5-Aminolevulinic Acid (also known as 5-ALA, and composed of aminolevulinic acid hydrochloride) is an optical imaging agent for use in patients with high-grade gliomas. Nicknamed the “pink drink,” 5-ALA is a surgical…...

Read more

When The Internet First Took On Cancer

It was 2001 and Graham Richards, Ph.D., a scientist funded from 1982 to 2007 by the National Foundation for Cancer Research, was faced with a challenge: How to harness the power of a supercomputer for virtual cancer drug models when you have neither the budget nor the space required? The…...

Read more

Mary-Claire King: Sharpshooter with Breast Cancer in Her Sights

Cancer is complex. “Simple” is the last word that either layman or scientist would use to describe virtually any aspect of the disease. However, simply put, the health prospects of women worldwide have improved as a result of the laboratory work of Mary-Claire King, Ph.D., winner of the National Foundation…...

Read more

HPV Vaccine Gets Expanded Approval from FDA

The U.S. Food and Drug Administration (FDA) recently approved Gardasil 9, a human papilloma virus (HPV) vaccine, for adults aged 27 to 45. The move could help further spell the end of one of the main causes of a host of communicable cancers. Already approved for patients aged 9 to…...

Read more

Hormone Therapy: Influencing Breast Cancer Treatment and Beyond

While recent medical discoveries, from drugs to imaging techniques, continue to revolutionize cancer care, none of them would be possible without foundations having been laid years, or even decades, earlier. Groundbreaking work by the late endocrinologist Jack Gorski, Ph.D., who passed away in 2006 and was funded by the National…...

Read more

The Muscle Cancer That Isn’t

In a proof-positive that cancer research still has miles to cover, a pediatric cancer long associated with aberrant muscle cells has now been found to arise from cells that would normally develop into cells lining blood vessels. Oncologists at St. Jude Children’s Research Hospital researching rhabdomyosarcoma, the most prevalent soft…...

Read more